{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:06:11Z","timestamp":1774933571003,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia","award":["ISP-23-81"],"award-info":[{"award-number":["ISP-23-81"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11686-024-00899-8","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T11:03:03Z","timestamp":1723806183000},"page":"1439-1457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Novel Antileishmanial Chemotypes By High-Throughput Virtual and In Vitro Screening"],"prefix":"10.1007","volume":"69","author":[{"given":"Huma","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Ageeli","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubarak A.","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader S.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazif","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasool","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asaad","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf N.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-9277","authenticated-orcid":false,"given":"Abdul","family":"Wadood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"899_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-031-24355-4","volume-title":"Vaccines for neglected pathogens: strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis","author":"S Vermaak","year":"2023","unstructured":"Vermaak S, Sampson S, McShane H (2023) The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy. Vaccines for neglected pathogens: strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis. Springer, Cham, pp 11\u201325. https:\/\/doi.org\/10.1007\/978-3-031-24355-4"},{"issue":"4\u20135","key":"899_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","volume":"7","author":"M Ouellette","year":"2004","unstructured":"Ouellette M, Drummelsmith J, Papadopoulou B (2004) Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updates 7(4\u20135):257\u2013266. https:\/\/doi.org\/10.1016\/j.drup.2004.07.002","journal-title":"Drug Resist Updates"},{"key":"899_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.actatropica.2017.05.032","volume":"173","author":"A \u00d6zbilgin","year":"2017","unstructured":"\u00d6zbilgin A et al (2017) Leishmaniasis in Turkey: visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey. Acta Trop 173:90\u201396. https:\/\/doi.org\/10.1016\/j.actatropica.2017.05.032","journal-title":"Acta Trop"},{"key":"899_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/9780470688618.taw0182","volume-title":"Topley & Wilson\u2019s microbiology and microbial infections","author":"R Lainson","year":"2010","unstructured":"Lainson R, Shaw J (2010) New World leishmaniasis. Topley & Wilson\u2019s microbiology and microbial infections. John Wiley & Sons Ltd., New York. https:\/\/doi.org\/10.1002\/9780470688618.taw0182"},{"issue":"2","key":"899_CR5","first-page":"4057","volume":"20","author":"LTY Lazar","year":"2020","unstructured":"Lazar LTY, Abass KS (2020) Morphology, life cycle, pathogenesis and virulence factors of genus Leishmania: a review. Plant Arch 20(2):4057\u20134060","journal-title":"Plant Arch"},{"issue":"1","key":"899_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1080\/13880209.2017.1285946","volume":"55","author":"A Das","year":"2017","unstructured":"Das A et al (2017) Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa. Pharm Biol 55(1):998\u20131009. https:\/\/doi.org\/10.1080\/13880209.2017.1285946","journal-title":"Pharm Biol"},{"issue":"1","key":"899_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpara.2016.09.007","volume":"47","author":"NJ Beesley","year":"2017","unstructured":"Beesley NJ et al (2017) Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance. Int J Parasitol 47(1):11\u201320. https:\/\/doi.org\/10.1016\/j.ijpara.2016.09.007","journal-title":"Int J Parasitol"},{"issue":"1","key":"899_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41579-022-00777-y","volume":"21","author":"M De Rycker","year":"2023","unstructured":"De Rycker M et al (2023) Anti-trypanosomatid drug discovery: progress and challenges. Nat Rev Microbiol 21(1):35\u201350. https:\/\/doi.org\/10.1038\/s41579-022-00777-y","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"899_CR9","doi-asserted-by":"publisher","first-page":"20228136","DOI":"10.1515\/gps-2022-8136","volume":"12","author":"H Ali","year":"2023","unstructured":"Ali H et al (2023) Synthesis, characterization, anticancer, anti-inflammatory activities, and docking studies of 3, 5-disubstituted thiadiazine-2-thiones. Green Process Synth 12(1):20228136. https:\/\/doi.org\/10.1515\/gps-2022-8136","journal-title":"Green Process Synth"},{"issue":"12","key":"899_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2174\/1570180816666190221163641","volume":"16","author":"M Khan","year":"2019","unstructured":"Khan M et al (2019) Biology-oriented drug synthesis (BIODS), structural characterization and bioactivities of novel albendazole derivatives. Lett Drug Des Discov 16(12):1329\u20131338. https:\/\/doi.org\/10.2174\/1570180816666190221163641","journal-title":"Lett Drug Des Discov"},{"key":"899_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cropro.2017.06.013","volume":"100","author":"L Mao","year":"2017","unstructured":"Mao L et al (2017) Efficacy of soil fumigation with dazomet for controlling ginger bacterial wilt (Ralstonia solanacearum) in China. Crop Prot 100:111\u2013116. https:\/\/doi.org\/10.1016\/j.cropro.2017.06.013","journal-title":"Crop Prot"},{"issue":"17","key":"899_CR12","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1021\/jf0202436","volume":"50","author":"CB Vicentini","year":"2002","unstructured":"Vicentini CB et al (2002) Development of new fungicides against Magnaporthe grisea: synthesis and biological activity of pyrazolo [3, 4-d][1, 3] thiazine, pyrazolo [1, 5-c][1, 3, 5] thiadiazine, and pyrazolo [3, 4-d] pyrimidine derivatives. J Agric Food Chem 50(17):4839\u20134845. https:\/\/doi.org\/10.1021\/jf0202436","journal-title":"J Agric Food Chem"},{"issue":"10","key":"899_CR13","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1021\/jf0500029","volume":"53","author":"CB Vicentini","year":"2005","unstructured":"Vicentini CB et al (2005) Pyrazole derivatives as photosynthetic electron transport inhibitors: new leads and structure\u2212activity relationship. J Agric Food Chem 53(10):3848\u20133855. https:\/\/doi.org\/10.1021\/jf0500029","journal-title":"J Agric Food Chem"},{"issue":"4","key":"899_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00044-018-2133-9","volume":"27","author":"A-N El-Shorbagi","year":"2018","unstructured":"El-Shorbagi A-N et al (2018) Bis-(5-substituted-2-thiono-1, 3, 5-thiadiazinan-3-yl) butane as a scaffold of anti-proliferative activity, blended by a multicomponent process. Med Chem Res 27(4):1103\u20131110. https:\/\/doi.org\/10.1007\/s00044-018-2133-9","journal-title":"Med Chem Res"},{"issue":"3","key":"899_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1573406411006030144","volume":"6","author":"MH Semreen","year":"2010","unstructured":"Semreen MH et al (2010) Targeting \u03b3-aminobutyric acid (GABA) carriers to the brain: potential relevance as antiepileptic pro-drugs. Med Chem 6(3):144\u2013149. https:\/\/doi.org\/10.2174\/1573406411006030144","journal-title":"Med Chem"},{"issue":"19","key":"899_CR16","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.bmcl.2018.07.045","volume":"28","author":"N Arshad","year":"2018","unstructured":"Arshad N et al (2018) New series of 3, 5-disubstituted tetrahydro-2H-1, 3, 5-thiadiazine thione (THTT) derivatives: synthesis and potent antileishmanial activity. Bioorg Med Chem Lett 28(19):3251\u20133254. https:\/\/doi.org\/10.1016\/j.bmcl.2018.07.045","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"899_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42452-021-04375-0","volume":"3","author":"J Coro-Bermello","year":"2021","unstructured":"Coro-Bermello J et al (2021) Identification of novel thiadiazin derivatives as potentially selective inhibitors towards trypanothione reductase from Trypanosoma cruzi by molecular docking using the numerical index poses ratio Pr and the binding mode analysis. SN Appl Sci 3(3):1\u201320. https:\/\/doi.org\/10.1007\/s42452-021-04375-0","journal-title":"SN Appl Sci"},{"issue":"15","key":"899_CR18","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1016\/j.bmcl.2007.05.020","volume":"17","author":"X Ji","year":"2007","unstructured":"Ji X et al (2007) Preparation of 1, 3, 5-thiadiazine-2-thione derivatives of chitosan and their potential antioxidant activity in vitro. Bioorg Med Chem Lett 17(15):4275\u20134279. https:\/\/doi.org\/10.1016\/j.bmcl.2007.05.020","journal-title":"Bioorg Med Chem Lett"},{"issue":"20","key":"899_CR19","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1016\/S0968-0896(03)00480-2","volume":"11","author":"D Katiyar","year":"2003","unstructured":"Katiyar D et al (2003) Synthesis and antimycobacterial activity of 3, 5-disubstituted thiadiazine thiones. Bioorg Med Chem 11(20):4369\u20134375. https:\/\/doi.org\/10.1016\/S0968-0896(03)00480-2","journal-title":"Bioorg Med Chem"},{"key":"899_CR20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7581","volume":"7","author":"J Yan","year":"2019","unstructured":"Yan J et al (2019) Design, synthesis and antimicrobial activities of novel 1, 3, 5-thiadiazine-2-thione derivatives containing a 1, 3, 4-thiadiazole group. PeerJ 7:e7581. https:\/\/doi.org\/10.7717\/peerj.7581","journal-title":"PeerJ"},{"issue":"1","key":"899_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/14756366.2017.1410480","volume":"33","author":"M Tonelli","year":"2018","unstructured":"Tonelli M et al (2018) Benzimidazole derivatives endowed with potent antileishmanial activity. J Enzym Inhib Med Chem 33(1):210\u2013226. https:\/\/doi.org\/10.1080\/14756366.2017.1410480","journal-title":"J Enzym Inhib Med Chem"},{"issue":"2","key":"899_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1021\/acs.jcim.9b00020","volume":"59","author":"BP Brown","year":"2019","unstructured":"Brown BP, Mendenhall J, Meiler J (2019) BCL: MolAlign: three-dimensional small molecule alignment for pharmacophore mapping. J Chem Inf Model 59(2):689\u2013701. https:\/\/doi.org\/10.1021\/acs.jcim.9b00020","journal-title":"J Chem Inf Model"},{"issue":"2\u20133","key":"899_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.actatropica.2011.05.017","volume":"119","author":"N Shakya","year":"2011","unstructured":"Shakya N et al (2011) Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator\u2014Picroliv. Acta Trop 119(2\u20133):188\u2013193. https:\/\/doi.org\/10.1016\/j.actatropica.2011.05.017","journal-title":"Acta Trop"},{"issue":"3","key":"899_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10822-019-00226-8","volume":"29","author":"NA Al-Shar\u2019i","year":"2019","unstructured":"Al-Shar\u2019i NA et al (2019) Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking. Med Chem Res 29(3):356\u2013376. https:\/\/doi.org\/10.1007\/s10822-019-00226-8","journal-title":"Med Chem Res"},{"issue":"W1","key":"899_CR25","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P et al (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46(W1):W257\u2013W263. https:\/\/doi.org\/10.1093\/nar\/gky318","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"899_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):1\u201313. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"9","key":"899_CR27","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"issue":"8","key":"899_CR28","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1021\/jm900185q","volume":"52","author":"P Baiocco","year":"2009","unstructured":"Baiocco P et al (2009) Molecular basis of antimony treatment in leishmaniasis. J Med Chem 52(8):2603\u20132612. https:\/\/doi.org\/10.1021\/jm900185q","journal-title":"J Med Chem"},{"issue":"25","key":"899_CR29","doi-asserted-by":"publisher","first-page":"17672","DOI":"10.1074\/jbc.M801850200","volume":"283","author":"PK Fyfe","year":"2008","unstructured":"Fyfe PK et al (2008) Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities. J Biol Chem 283(25):17672\u201317680. https:\/\/doi.org\/10.1074\/jbc.M801850200","journal-title":"J Biol Chem"},{"issue":"3","key":"899_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert J-P, Ciccotti G, Berendsen HJ (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23(3):327\u2013341. https:\/\/doi.org\/10.1016\/0021-9991(77)90098-5","journal-title":"J Comput Phys"},{"issue":"9","key":"899_CR31","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R et al (2013) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J Chem Theory Comput 9(9):3878\u20133888. https:\/\/doi.org\/10.1021\/ct400314y","journal-title":"J Chem Theory Comput"},{"issue":"11","key":"899_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000222","volume":"4","author":"LG Ng","year":"2008","unstructured":"Ng LG et al (2008) Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog 4(11):e1000222. https:\/\/doi.org\/10.1371\/journal.ppat.1000222","journal-title":"PLoS Pathog"},{"issue":"12","key":"899_CR33","doi-asserted-by":"publisher","first-page":"pdb. prot5080","DOI":"10.1101\/pdb.prot5080","volume":"2008","author":"J Weischenfeldt","year":"2008","unstructured":"Weischenfeldt J, Porse B (2008) Bone marrow-derived macrophages (BMM): isolation and applications. Cold Spring Harbor Protoc 2008(12):pdb. prot5080. https:\/\/doi.org\/10.1101\/pdb.prot5080","journal-title":"Cold Spring Harbor Protoc"},{"issue":"3","key":"899_CR34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1096\/fj.15-277202","volume":"30","author":"C Terrazas","year":"2016","unstructured":"Terrazas C et al (2016) IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani. FASEB J 30(3):1135. https:\/\/doi.org\/10.1096\/fj.15-277202","journal-title":"FASEB J"},{"issue":"12","key":"899_CR35","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/ptr.5204","volume":"28","author":"F Abeje","year":"2014","unstructured":"Abeje F et al (2014) Phytochemistry and antileishmanial activity of the leaf latex of Aloe calidophila Reynolds. Phytother Res 28(12):1801\u20131805. https:\/\/doi.org\/10.1002\/ptr.5204","journal-title":"Phytother Res"},{"key":"899_CR36","unstructured":"Prism G IC50 calculation with nonlinear regression curve was performed using GraphPad Prism version 5.00 for windows, GraphPad software, San Diego California USA. www.graphpad.com"},{"key":"899_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/B978-0-12-815723-7.00008-0","volume-title":"Discovery and development of therapeutics from natural products against neglected tropical diseases","author":"N Tiwari","year":"2019","unstructured":"Tiwari N et al (2019) Leishmaniasis control: limitations of current drugs and prospects of natural products. Discovery and development of therapeutics from natural products against neglected tropical diseases. Elsevier, Amsterdam, pp 293\u2013350. https:\/\/doi.org\/10.1016\/B978-0-12-815723-7.00008-0"},{"key":"899_CR38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejmech.2018.01.043","volume":"146","author":"P Linciano","year":"2018","unstructured":"Linciano P et al (2018) Aryl thiosemicarbazones for the treatment of trypanosomatidic infections. Eur J Med Chem 146:423\u2013434. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.043","journal-title":"Eur J Med Chem"},{"key":"899_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2020.e00143","volume":"9","author":"A Phumee","year":"2020","unstructured":"Phumee A et al (2020) Determination of anti-leishmanial drugs efficacy against Leishmania martiniquensis using a colorimetric assay. Parasite Epidemiol Control 9:e00143. https:\/\/doi.org\/10.1016\/j.parepi.2020.e00143","journal-title":"Parasite Epidemiol Control"},{"issue":"19","key":"899_CR40","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1073\/pnas.1820175116","volume":"116","author":"S Wyllie","year":"2019","unstructured":"Wyllie S et al (2019) Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition. Proc Natl Acad Sci 116(19):9318\u20139323. https:\/\/doi.org\/10.1073\/pnas.1820175116","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"899_CR41","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.drudis.2019.03.007","volume":"24","author":"R Bala\u00f1a-Fouce","year":"2019","unstructured":"Bala\u00f1a-Fouce R et al (2019) Walking a tightrope: drug discovery in visceral leishmaniasis. Drug Discov Today 24(5):1209\u20131216. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.007","journal-title":"Drug Discov Today"},{"issue":"22","key":"899_CR42","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/cr500365f","volume":"114","author":"AS Nagle","year":"2014","unstructured":"Nagle AS et al (2014) Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev 114(22):11305\u201311347. https:\/\/doi.org\/10.1021\/cr500365f","journal-title":"Chem Rev"},{"issue":"8","key":"899_CR43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1515\/pac-2018-1102","volume":"91","author":"RM Reguera","year":"2019","unstructured":"Reguera RM et al (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure Appl Chem 91(8):1385\u20131404. https:\/\/doi.org\/10.1515\/pac-2018-1102","journal-title":"Pure Appl Chem"},{"issue":"7717","key":"899_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","volume":"560","author":"S Wyllie","year":"2018","unstructured":"Wyllie S et al (2018) Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis. Nature 560(7717):192\u2013197. https:\/\/doi.org\/10.1038\/s41586-018-0356-z","journal-title":"Nature"},{"key":"899_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112146","volume":"191","author":"F Mathias","year":"2020","unstructured":"Mathias F et al (2020) Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents. Eur J Med Chem 191:112146. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112146","journal-title":"Eur J Med Chem"},{"key":"899_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","volume":"17","author":"S Pal","year":"2019","unstructured":"Pal S et al (2019) Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors. Comput Struct Biotechnol J 17:291\u2013310. https:\/\/doi.org\/10.1016\/j.csbj.2019.02.006","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"899_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097600","volume":"9","author":"A Equbal","year":"2014","unstructured":"Equbal A et al (2014) Stage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovani. PLoS ONE 9(6):e97600. https:\/\/doi.org\/10.1371\/journal.pone.0097600","journal-title":"PLoS ONE"},{"issue":"7","key":"899_CR48","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/cmdc.201300176","volume":"8","author":"P Baiocco","year":"2013","unstructured":"Baiocco P et al (2013) Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by x-ray crystallography. ChemMedChem 8(7):1175\u20131183. https:\/\/doi.org\/10.1002\/cmdc.201300176","journal-title":"ChemMedChem"},{"issue":"52","key":"899_CR49","doi-asserted-by":"publisher","first-page":"36137","DOI":"10.1074\/jbc.M109.045336","volume":"284","author":"LS Torrie","year":"2009","unstructured":"Torrie LS et al (2009) Chemical validation of trypanothione synthetase. J Biol Chem 284(52):36137\u201336145. https:\/\/doi.org\/10.1074\/jbc.M109.045336","journal-title":"J Biol Chem"},{"key":"899_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy552","author":"S Varikuti","year":"2019","unstructured":"Varikuti S et al (2019) The potent ITK\/BTK inhibitor ibrutinib is effective for the treatment of experimental Visceral Leishmaniasis caused by Leishmania donovani. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiy552","journal-title":"J Infect Dis"},{"issue":"9","key":"899_CR51","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1128\/AAC.00548-09","volume":"53","author":"M Vermeersch","year":"2009","unstructured":"Vermeersch M et al (2009) In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences. Antimicrob Agents Chemother 53(9):3855\u20133859","journal-title":"Antimicrob Agents Chemother"},{"key":"899_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-814427-5.00008-1","volume-title":"Biomaterials and bionanotechnology","author":"V Soni","year":"2019","unstructured":"Soni V et al (2019) Novel therapeutic approaches for the treatment of Leishmaniasis. Biomaterials and bionanotechnology. Elsevier, Amsterdam, pp 263\u2013300"},{"key":"899_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pharmtox-011112-140248","volume":"53","author":"JP Bai","year":"2013","unstructured":"Bai JP, Abernethy DR (2013) Systems pharmacology to predict drug toxicity: integration across levels of biological organization. Annu Rev Pharmacol Toxicol 53:451\u2013473. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140248","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"899_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-019-1826-1","volume":"9","author":"S Mehwish","year":"2019","unstructured":"Mehwish S et al (2019) Natural compounds from plants controlling leishmanial growth via DNA damage and inhibiting trypanothione reductase and trypanothione synthetase: an in vitro and in silico approach. 3 Biotech 9:1\u201314. https:\/\/doi.org\/10.1007\/s13205-019-1826-1","journal-title":"3 Biotech"},{"issue":"19","key":"899_CR55","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.3390\/molecules26195843","volume":"26","author":"S Mehwish","year":"2021","unstructured":"Mehwish S et al (2021) Bioflavonoid-induced apoptosis and DNA Damage in amastigotes and promastigotes of Leishmania donovani: deciphering the mode of action. Molecules 26(19):5843. https:\/\/doi.org\/10.3390\/molecules26195843","journal-title":"Molecules"},{"key":"899_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42452-021-04375-0","volume":"3","author":"J Coro-Bermello","year":"2021","unstructured":"Coro-Bermello J et al (2021) Identification of novel thiadiazin derivatives as potentially selective inhibitors towards trypanothione reductase from Trypanosoma cruzi by molecular docking using the numerical index poses ratio Pr and the binding mode analysis. SN Appl Sci 3:1\u201320. https:\/\/doi.org\/10.1007\/s42452-021-04375-0","journal-title":"SN Appl Sci"},{"key":"899_CR57","unstructured":"El-Shorbagi AN et al Targeting some THTT derivatives as scaffold for dopamine to CNS, neuroprotective agents, computation and docking on GSK-3"},{"issue":"8","key":"899_CR58","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/molecules24081557","volume":"24","author":"G Serban","year":"2019","unstructured":"Serban G (2019) Future prospects in the treatment of parasitic diseases: 2-amino-1, 3, 4-thiadiazoles in leishmaniasis. Molecules 24(8):1557. https:\/\/doi.org\/10.3390\/molecules24081557","journal-title":"Molecules"},{"key":"899_CR59","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S354779","author":"K Rahman","year":"2022","unstructured":"Rahman K et al (2022) Analagesic and anti-inflammatory potentials of a less ulcerogenic thiadiazinethione derivative in animal models: biochemical and histochemical correlates. Drug Design Dev Therapy. https:\/\/doi.org\/10.2147\/DDDT.S354779","journal-title":"Drug Design Dev Therapy"},{"key":"899_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.100925","author":"O Ebenezer","year":"2023","unstructured":"Ebenezer O et al (2023) Benzimidazole and its derivatives: recent advances (2020\u20132022). Results Chem. https:\/\/doi.org\/10.1016\/j.rechem.2023.100925","journal-title":"Results Chem"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-024-00899-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:26:13Z","timestamp":1725614773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-024-00899-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1007\/s11686-024-00899-8","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"In our study the informed consent is not needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}